订阅小程序
旧版功能

Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (chl), Results of SWOG S1826

Sharon M. Castellino,Hongli Li,Alex F. Herrera,Angela Punnett,Michael Leblanc,Susan K. Parsons,David Hodgson,Frank Keller,Richard A. Drachtman,Adam Lamble,Christopher J. Forlenza,Andrew Doan,Sarah C. Rutherford,Andrew M. Evens,Richard F. Little,Malcolm A. Smith,Joo Y. Song,Sonali M. Smith,Jonathan W. Friedberg,Kara M. Kelly

BLOOD（2023）

引用 4|浏览2
关键词
Rituximab Therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要